This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXNPEC0Q0MJ_M.jpg
The pharma sector is expected to experience rapid growth due to positive sentiments fueled by increasing vaccination drives globally, surging demand for customized medicines and healthcare products, and increasing investments in R&D for developing drugs to meet growing demand from an aging population. The global pharmaceuticals market is expected to reach $1700.97 billion in 2025, representing an 8% CAGR.
As such, we think major companies in this space, Johnson & Johnson (JNJ), Pfizer Inc. (NYSE:PFE), and Bristol-Myers Squibb Co. (BMY), which are investing heavily in R&D to diversify their portfolios and are expected to maintain strong financials, should deliver excellent returns this year and beyond as demand for vaccines and healthcare products continue to soar.
